The traditional relationship between Momentum and Value factors is becoming increasingly blurred as the Covid-19 pandemic has upended equity markets, according to Unigestion.
New research from Unigestion’s equities team suggests investor confidence has been dented in recent weeks as the Delta variant has taken hold in several countries that had earlier been buoyed by the vaccine rollout. Earlier, the stock market rally towards the end of 2020 into 2021 – propelled by the vaccine push – had reversed the fortunes of certain so-called Covid “winner” and “loser” equities, such as healthcare and software.
Unigestion said this ‘winners and losers’ theme in equities, which emerged out of the disruption of the pandemic, has underpinned the performance of both Momentum and Value names for much of the past year – but is now being disrupted as investors shift their focus toward economic reopening and recovery.
“As sentiment changed following the ‘Vaccine Rally’, Value has enjoyed a strong run of performance. A natural conclusion might be that, as Momentum and Value have coalesced, Value’s relationship with the Covid bet has also weakened,” analysts observed in a market commentary.
“The result is an equity factor suite that is better diversified, capturing a greater set of effective bets.”
Unigestion data shows that, in January, Momentum still dominated the Covid bet, with roughly 60 per cent of longs and shorts remaining in their top and bottom deciles, respectively.
But by April, Momentum “had lost much of its Covid bet”, and by early July a large proportion of stocks held long basket in October had now been moved to the short basket – “a partial inversion of the portfolio held only six months earlier”, according to Unigestion’s data, underlining the extent of the shift.
“Healthcare stocks which might have benefitted from the pandemic have reverted sharply. Similarly, some software companies which initially benefited from the remote working scenario now constitute some of the poorest recent performers,” the note said. “While materials stocks may be considered more cyclical, we see precious metals miners transitioning from long to short.”
Analysts believes Momentum has changed character dramatically, partly as a result of the “neutralisation” of the Covid bet that dominated 2020.
“While its relationship with Value has also shifted, we do not see evidence that Value has lost its sensitivity to the Covid bet.”
Unigestion added: “Where Momentum gains would have once offset Value losses – and vice versa – the relationship between the two is likely to be much more blurry going forward. At the factor portfolio level, rather than having two broadly cancelling positions, we should enjoy a more diversified set of returns.”
Newsletter
Like this article?
Sign up to our free newsletter
The Covid bet: How the pandemic has disrupted the Momentum-Value equity equation
Related Topics
The traditional relationship between Momentum and Value factors is becoming increasingly blurred as the Covid-19 pandemic has upended equity markets, according to Unigestion.
New research from Unigestion’s equities team suggests investor confidence has been dented in recent weeks as the Delta variant has taken hold in several countries that had earlier been buoyed by the vaccine rollout. Earlier, the stock market rally towards the end of 2020 into 2021 – propelled by the vaccine push – had reversed the fortunes of certain so-called Covid “winner” and “loser” equities, such as healthcare and software.
Unigestion said this ‘winners and losers’ theme in equities, which emerged out of the disruption of the pandemic, has underpinned the performance of both Momentum and Value names for much of the past year – but is now being disrupted as investors shift their focus toward economic reopening and recovery.
“As sentiment changed following the ‘Vaccine Rally’, Value has enjoyed a strong run of performance. A natural conclusion might be that, as Momentum and Value have coalesced, Value’s relationship with the Covid bet has also weakened,” analysts observed in a market commentary.
“The result is an equity factor suite that is better diversified, capturing a greater set of effective bets.”
Unigestion data shows that, in January, Momentum still dominated the Covid bet, with roughly 60 per cent of longs and shorts remaining in their top and bottom deciles, respectively.
But by April, Momentum “had lost much of its Covid bet”, and by early July a large proportion of stocks held long basket in October had now been moved to the short basket – “a partial inversion of the portfolio held only six months earlier”, according to Unigestion’s data, underlining the extent of the shift.
“Healthcare stocks which might have benefitted from the pandemic have reverted sharply. Similarly, some software companies which initially benefited from the remote working scenario now constitute some of the poorest recent performers,” the note said. “While materials stocks may be considered more cyclical, we see precious metals miners transitioning from long to short.”
Analysts believes Momentum has changed character dramatically, partly as a result of the “neutralisation” of the Covid bet that dominated 2020.
“While its relationship with Value has also shifted, we do not see evidence that Value has lost its sensitivity to the Covid bet.”
Unigestion added: “Where Momentum gains would have once offset Value losses – and vice versa – the relationship between the two is likely to be much more blurry going forward. At the factor portfolio level, rather than having two broadly cancelling positions, we should enjoy a more diversified set of returns.”
Like this article? Sign up to our free newsletter
Most Popular
Encore Compliance launches surveillance tech for MNPI and insider trading controls
Garda adds JPMorgan MD to Singapore office
Man Group appoints Senior MD to focus on private credit and direct lending
MFA calls on FCA to withdraw name and shame proposal
Sculptor closes €354m European CLO XI
Further Reading
Basis trade crackdown could pose credit market risk, says UBS
Hedge funds are ‘dead as a doornail’ for UHNWIs, says Tiger 21 boss
Hong Kong hedge fund ActusRay doubles assets to over $700m
Hedge funds up tech stock allocations
Digital assets funds see third week of outflows
Hedge fund Weiss files for bankruptcy following wind down
Over 90% of alt fund managers using AI for risk and compliance
Clear Street launches futures clearing services
Featured
Hedge funds are ‘dead as a doornail’ for UHNWIs, says Tiger 21 boss
Multi-strat launches dive in Q1, says Preqin
Elliott holds $1bn stake in Anglo American
Hedge fund boss believes cum-ex trades were ‘completely legal’
Quants rack up big Q1 gains
Activist JANA wants Wolfspeed to consider sale
Hedge fund assets hit record $4.3tn, says HFR
Investors pull $1.6bn from Man Group in Q1